CLINICAL_TRIALS
trial_result
· 2023-11-08
Clinical Trial Update: Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer [NA]
Summary
Trial results for TheraSphere in patients with unresectable hepatocellular carcinoma have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Unresectable Hepatocellular Carcinoma | NA | Status: COMPLETED | Results posted: 2023-11-08